Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
The latest announcement is out from Clover Corporation Limited ( (AU:CLV) ).
Clover Corporation Limited announced a change in the director’s interest, with Fiona Pearse acquiring an additional 14,492 ordinary shares through an on-market purchase, increasing her total holdings to 55,032 shares. This acquisition reflects a continued commitment to the company and may indicate confidence in its future performance, potentially impacting stakeholders’ perceptions and the company’s market positioning.
The most recent analyst rating on (AU:CLV) stock is a Buy with a A$0.75 price target. To see the full list of analyst forecasts on Clover Corporation Limited stock, see the AU:CLV Stock Forecast page.
More about Clover Corporation Limited
Clover Corporation Limited operates in the health and nutrition industry, focusing on the development and supply of innovative products and technologies. The company specializes in microencapsulation technology, which is used to enhance the stability and delivery of bioactive ingredients in food and pharmaceutical products.
Average Trading Volume: 149,822
Technical Sentiment Signal: Hold
Current Market Cap: A$115.2M
For detailed information about CLV stock, go to TipRanks’ Stock Analysis page.